seqWell
Beverly, US · Founded 2014 · Delaware corporation · 1 known investors
Founders & leadership
TG
Thomas GrantExecutive
DC
Daniel CalvoExecutive
JM
Joseph MellorNamed on SEC filing
JM
Joseph Mellor, Ph.D.Named on SEC filing
Board
AL
Amy LiaoBoard director
CS
Chad SouvignierBoard director
AP
Anup ParikhBoard director
MF
Michael FinneyBoard director
PM
Paul McEwanBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$22.5M disclosed across 8 rounds · 2016–2025
▶$3.1MraisedFeb 2025 · 11 investors · Other TechnologyRule 506(b)
▶$3.1MraisedFeb 2025 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MellorExecutive Officer, Director
- Chad SouvignierDirector
- Daniel CalvoExecutive Officer, Director
- Paul McEwanDirector
- Amy LiaoDirector
- Michael FinneyDirector
- Thomas GrantExecutive Officer
- Anup ParikhDirector
- Offering amount
- $3.5M
- Amount sold
- $3.1M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.5KraisedJan 2025 · 1 investors · Other TechnologyRule 506(b)
▶$11.5KraisedJan 2025 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas GrantExecutive Officer
- Amy LiaoDirector
- Chad SouvignierDirector
- Joseph MellorExecutive Officer, Director
- Daniel CalvoExecutive Officer, Director
- Anup ParikhDirector
- Michael FinneyDirector
- Paul McEwanDirector
- Offering amount
- $11.5K
- Amount sold
- $11.5K
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4KraisedSep 2023 · 14 investors · Other TechnologyRule 506(b)
▶$3.4KraisedSep 2023 · 14 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MellorExecutive Officer, Director
- Amy LiaoDirector
- Paul McEwanDirector
- Dan CalvoExecutive Officer, Director
- Chad SouvignierDirector
- Michael FinneyDirector
- Thomas GrantExecutive Officer
- Offering amount
- $6.5K
- Amount sold
- $3.4K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedSep 2023 · 14 investors · Other TechnologyRule 506(b)
▶$3.4MraisedSep 2023 · 14 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MellorExecutive Officer, Director
- Paul McEwanDirector
- Thomas GrantExecutive Officer
- Michael FinneyDirector
- Amy LiaoDirector
- Dan CalvoExecutive Officer, Director
- Chad SouvignierDirector
- Offering amount
- $6.5M
- Amount sold
- $3.4M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedMar 2022 · 10 investors · Other TechnologyRule 506(b)
▶$7MraisedMar 2022 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MellorExecutive Officer, Director
- Chad SoveignerDirector
- Thomas H. GrantExecutive Officer
- Rob WilsonDirector
- Dan CalvoExecutive Officer, Director
- Paul McEwanDirector
- Michael FinneyDirector
- Offering amount
- $8M
- Amount sold
- $7M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedJan 2020 · 23 investors · Other TechnologyRule 506(b)
▶$7MraisedJan 2020 · 23 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael FinneyDirector
- Joseph C. MellorExecutive Officer, Director
- Paul McEwanDirector
- Offering amount
- $9.3M
- Amount sold
- $7M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$700KraisedMay 2017 · 13 investors · BiotechnologyRule 506(b)
▶$700KraisedMay 2017 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jack LeonardExecutive Officer
- Tom GrantExecutive Officer
- William McKenzieDirector
- Joseph Mellor, Ph.D.Executive Officer, Director
- Michael FinneyDirector
- Offering amount
- $800K
- Amount sold
- $700K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.3MraisedJul 2016 · 15 investors · BiotechnologyRule 506(b)
▶$1.3MraisedJul 2016 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph Mellor, Ph.D.Executive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
IDbyDNA144 shared keywordsScalable, high throughput DNA sequencing platforms.
Oup108 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Genewiz50 shared keywordsGENEWIZ, part of Azenta Life Sciences, provides genomics laboratory services including next-generation and Sanger sequencing, gene synthesis, oligo synthesis, plasmid DNA preparation, proteomics, and GLP-compliant and clinical services. It serves researchers and life science organizations working in areas such as cancer genomics, cell and gene therapy, synthetic biology, and infectious disease.
Companies competing with seqWell for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who are seqWell's investors?
- seqWell's investors include Research Corporation Technologies.
- How much funding has seqWell raised?
- seqWell has disclosed $22.5M raised across 8 rounds.
- Where is seqWell headquartered?
- seqWell is headquartered in Beverly, US.